These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 36312533)

  • 1. The use of predictive models to develop chromatography-based purification processes.
    Bernau CR; Knödler M; Emonts J; Jäpel RC; Buyel JF
    Front Bioeng Biotechnol; 2022; 10():1009102. PubMed ID: 36312533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model based process optimization of an industrial chromatographic process for separation of lactoferrin from bovine milk.
    Gerstweiler L; Schad P; Trunzer T; Enghauser L; Mayr M; Billakanti J
    J Chromatogr A; 2023 Nov; 1710():464428. PubMed ID: 37797420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Throughput Process Development for the Chromatographic Purification of Viral Antigens.
    Jacob SI; Konstantinidis S; Bracewell DG
    Methods Mol Biol; 2021; 2183():119-182. PubMed ID: 32959244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An accelerated approach for mechanistic model based prediction of linear gradient elution ion-exchange chromatography of proteins.
    Shekhawat LK; Tiwari A; Yamamoto S; Rathore AS
    J Chromatogr A; 2022 Sep; 1680():463423. PubMed ID: 36001907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From protein structure to an optimized chromatographic capture step using multiscale modeling.
    Keulen D; Neijenhuis T; Lazopoulou A; Disela R; Geldhof G; Le Bussy O; Klijn ME; Ottens M
    Biotechnol Prog; 2024 Sep; ():e3505. PubMed ID: 39344097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein purification using chromatography: selection of type, modelling and optimization of operating conditions.
    Asenjo JA; Andrews BA
    J Mol Recognit; 2009; 22(2):65-76. PubMed ID: 18546092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downstream Processing Technologies/Capturing and Final Purification : Opportunities for Innovation, Change, and Improvement. A Review of Downstream Processing Developments in Protein Purification.
    Singh N; Herzer S
    Adv Biochem Eng Biotechnol; 2018; 165():115-178. PubMed ID: 28795201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Modeling of Preparative Column Chromatography for Biotherapeutics.
    Kumar V; Lenhoff AM
    Annu Rev Chem Biomol Eng; 2020 Jun; 11():235-255. PubMed ID: 32513085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive assessment of the applicability of RoboColumn as a chromatography scale-down model for use in biopharmaceutical process validation.
    Chinn M; Doninger K; Al-Khaledy R; Zhang E; Kim H; Werz S; Schelter F
    J Chromatogr A; 2023 Nov; 1710():464391. PubMed ID: 37769427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spherical nanoparticles can be used as non-penetrating tracers to determine the extra-particle void volume in packed-bed chromatography columns.
    Frank K; Bernau CR; Buyel JF
    J Chromatogr A; 2022 Jul; 1675():463174. PubMed ID: 35635874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of mechanistic modeling of liquid chromatography.
    Shekhawat LK; Rathore AS
    Prep Biochem Biotechnol; 2019; 49(6):623-638. PubMed ID: 31107163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput in silico workflow for optimization and characterization of multimodal chromatographic processes.
    Altern SH; Lyall JY; Welsh JP; Burgess S; Kumar V; Williams C; Lenhoff AM; Cramer SM
    Biotechnol Prog; 2024 Jun; ():e3483. PubMed ID: 38856182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of hydrophobic interaction chromatography for the separation of antibody-drug conjugates and its application towards quality by design.
    Andris S; Hubbuch J
    J Biotechnol; 2020 Jun; 317():48-58. PubMed ID: 32361022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined screening and in silico strategy for the rapid design of integrated downstream processes for process and product-related impurity removal.
    Vecchiarello N; Timmick SM; Goodwine C; Crowell LE; Love KR; Love JC; Cramer SM
    Biotechnol Bioeng; 2019 Sep; 116(9):2178-2190. PubMed ID: 31081177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity chromatography for vaccines manufacturing: Finally ready for prime time?
    Zhao M; Vandersluis M; Stout J; Haupts U; Sanders M; Jacquemart R
    Vaccine; 2019 Aug; 37(36):5491-5503. PubMed ID: 29627235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput process development: I. Process chromatography.
    Rathore AS; Bhambure R
    Methods Mol Biol; 2014; 1129():29-37. PubMed ID: 24648064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process development for robust removal of aggregates using cation exchange chromatography in monoclonal antibody purification with implementation of quality by design.
    Xu Z; Li J; Zhou JX
    Prep Biochem Biotechnol; 2012; 42(2):183-202. PubMed ID: 22394066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic chromatography-based purification strategies accelerate the development of downstream processes for biopharmaceutical proteins produced in plants.
    Buyel JF; Fischer R
    Biotechnol J; 2014 Apr; 9(4):566-77. PubMed ID: 24478119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Throughput Process Development: I-Process Chromatography.
    Rathore AS; Bhambure R
    Methods Mol Biol; 2021; 2178():11-20. PubMed ID: 33128739
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.